PMID 38646284
[DOI] [PubMed] [Google Scholar] 122.Sulyok M., Stadler D., Steiner D., Krska R
If you want to look at options, start with a clinician-led peptide therapy plan
The AGA and ACG provide evidence-based guidelines emphasizing treat-to-target strategies, with objective monitoring through endoscopy, cross-sectional imaging, and biomarkers (C-reactive protein, fecal calprotectin) to assess mucosal healing and optimize outcomes
Most of the symptoms are quite common across various conditions, such as lupus and iron deficiency
Treating low appetite in advanced cirrhosis should focus on addressing risk factors (such as active alcohol use, uncontrolled diabetes, and hypothyroidism), triggers (including hepatic encephalopathy, infections, electrolyte imbalances, and excessive medication burden), and related issues (such as removing symptomatic ascites, providing clear dietary recommendations, avoiding overly restrictive diets, and addressing mental health concerns) (Figure 3) ( Figure 3 4 Cirrhosis-related non-cholestatic pruritus 4.1 Prevalence and mechanisms Pruritus linked to liver ailments is particularly pronounced in chronic cholestatic liver conditions like primary biliary cholangitis and primary sclerosing cholangitis
